Hepcidin predicts 5-year mortality after community-acquired pneumonia

References

• World Health Organization. The top 10 causes of death [published 2020; updated 2020 Dec 09; cited 2021 June 05]. Available from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death.
   Google Scholar
• Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377–382.
   PubMed Web of Science ®Google Scholar
• Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336(4):243–250.
   PubMed Web of Science ®Google Scholar
• Viasus D, Del Rio-Pertuz G, Simonetti AF, et al. Biomarkers for predicting short-term mortality in community-acquired pneumonia: a systematic review and Meta-analysis. J Infect. 2016;72(3):273–282.
   PubMed Web of Science ®Google Scholar
• Xia JJ, Wang F, Jiang XN, et al. Serum iron levels are an independent predictor of in-hospital mortality of critically ill patients: a retrospective, single-institution study. J Int Med Res. 2019;47(1):66–75.
   PubMed Web of Science ®Google Scholar
• Tacke F, Nuraldeen R, Koch A, et al. Iron parameters determine the prognosis of critically ill patients. Crit Care Med. 2016;44(6):1049–1058.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Jiang FQ, Kong F, et al. Inflammatory anemia-associated parameters are related to 28-day mortality in patients with sepsis admitted to the ICU: a preliminary observational study. Ann Intensive Care. 2019;9(1):67.
   PubMedGoogle Scholar
• Lasocki S, Lefebvre T, Mayeur C, on behalf of the FROG-ICU study group, et al. Iron deficiency diagnosed using hepcidin on critical care discharge is an independent risk factor for death and poor quality of life at one year: an observational prospective study on 1161 patients. Crit Care. 2018;22(1):314. ).
   PubMedGoogle Scholar
• Taneri PE, Gomez-Ochoa SA, Llanaj E, et al. Anemia and iron metabolism in COVID-19: a systematic review and Meta-analysis. Eur J Epidemiol. 2020;35(8):763–773.
   PubMed Web of Science ®Google Scholar
• Zeng F, Huang Y, Guo Y, et al. Association of inflammatory markers with the severity of COVID-19: a Meta-analysis. Int J Infect Dis. 2020;96:467–474.
   PubMed Web of Science ®Google Scholar
• Nai A, Lorè NI, Pagani A, et al. Hepcidin levels predict covid-19 severity and mortality in a cohort of hospitalized italian patients. Am J Hematol. 2021;96(1):E32–e35.
   PubMed Web of Science ®Google Scholar
• Ganz T. Iron and infection. Int J Hematol. 2018;107(1):7–15.
   PubMed Web of Science ®Google Scholar
• Drakesmith H, Prentice AM. Hepcidin and the iron-infection axis. Science. 2012;338(6108):768–772.
   PubMed Web of Science ®Google Scholar
• Weiss G, Ganz T, Goodnough LT. Anemia of inflammation. Blood. 2019;133(1):40–50.
   PubMed Web of Science ®Google Scholar
• Holter JC, Muller F, Bjorang O, et al. Etiology of community-acquired pneumonia and diagnostic yields of microbiological methods: a 3-year prospective study in Norway. BMC Infect Dis. 2015;15(1):64.
   PubMedGoogle Scholar
• WHO. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. World Health Organization. Vitamin and mineral nutrition information system web site [published 2011; cited 2021 May 19]. Available from: http://www.who.int/vmnis/indicators/haemoglobin.pdf..
   Google Scholar
• Magnusson B, Örnemark U (eds.). Eurachem guide: the fitness for purpose of analytical methods – a laboratory guide to method validation and related topics. 2nd ed. 2014. Available from: http://www.eurachem.org
   Google Scholar
• Kemna EH, Tjalsma H, Podust VN, et al. Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications. Clin Chem. 2007;53(4):620–628.
   PubMed Web of Science ®Google Scholar
• Oppen K, Ueland T, Siljan WW, et al. Hepcidin and ferritin predict microbial etiology in Community-Acquired pneumonia. Open Forum Infect Dis. 2021;8(4):ofab082.
   PubMed Web of Science ®Google Scholar
• Siljan WW, Holter JC, Nymo SH, et al. Cytokine responses, microbial aetiology and short-term outcome in community-acquired pneumonia. Eur J Clin Invest. 2018;48(1):e12865.
   Web of Science ®Google Scholar
• Holter JC, Ueland T, Jenum PA, et al. Risk factors for long-term mortality after hospitalization for Community-Acquired pneumonia: a 5-Year prospective Follow-Up study. PLoS One. 2016;11(2):e0148741.
   PubMed Web of Science ®Google Scholar
• Reade MC, Weissfeld L, Angus DC, et al. The prevalence of anemia and its association with 90-day mortality in hospitalized community-acquired pneumonia. BMC Pulm Med. 2010;10(1):15.
   PubMedGoogle Scholar
• Doshi SM, Rueda AM, Corrales-Medina VF, et al. Anemia and community-acquired pneumococcal pneumonia. Infection. 2011;39(4):379–383.
   PubMed Web of Science ®Google Scholar
• Guertler C, Wirz B, Christ-Crain M, et al. Inflammatory responses predict long-term mortality risk in community-acquired pneumonia. Eur Respir J. 2011;37(6):1439–1446.
   PubMed Web of Science ®Google Scholar
• Girelli D, Nemeth E, Swinkels DW. Hepcidin in the diagnosis of iron disorders. Blood. 2016;127(23):2809–2813.
   PubMed Web of Science ®Google Scholar
• Sonnweber T, Nachbaur D, Schroll A, et al. Hypoxia induced downregulation of hepcidin is mediated by platelet derived growth factor BB. Gut. 2014;63(12):1951–1959.
   PubMed Web of Science ®Google Scholar
• Yağcı S, Serin E, Acicbe Ö, et al. The relationship between serum erythropoietin, hepcidin, and haptoglobin levels with disease severity and other biochemical values in patients with COVID-19. Int J Lab Hematol. 2021;43(S1):142–151.
   PubMedGoogle Scholar
• Grammer TB, Scharnagl H, Dressel A, et al. Iron metabolism, hepcidin, and mortality (the ludwigshafen risk and cardiovascular health study). Clin Chem. 2019;65(7):849–861.
   PubMed Web of Science ®Google Scholar